These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 16684029)

  • 1. Selective aldosterone blockade suppresses atrial tachyarrhythmias in heart failure.
    Shroff SC; Ryu K; Martovitz NL; Hoit BD; Stambler BS
    J Cardiovasc Electrophysiol; 2006 May; 17(5):534-41. PubMed ID: 16684029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldosterone blockade attenuates development of an electrophysiological substrate associated with ventricular tachyarrhythmias in heart failure.
    Stambler BS; Laurita KR; Shroff SC; Hoeker G; Martovitz NL
    Heart Rhythm; 2009 Jun; 6(6):776-83. PubMed ID: 19427273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldosterone antagonism as an antiarrhythmic approach for atrial arrhythmias in heart failure.
    Ram R; Van Wagoner DR
    J Cardiovasc Electrophysiol; 2006 May; 17(5):542-3. PubMed ID: 16684030
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of spironolactone on electrical and structural remodeling of atrium in congestive heart failure dogs.
    Yang SS; Han W; Zhou HY; Dong G; Wang BC; Huo H; Wei N; Cao Y; Zhou G; Xiu CH; Li WM
    Chin Med J (Engl); 2008 Jan; 121(1):38-42. PubMed ID: 18208664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of sustained atrial tachycardia in dogs with rapid ventricular pacing-induced heart failure.
    Stambler BS; Fenelon G; Shepard RK; Clemo HF; Guiraudon CM
    J Cardiovasc Electrophysiol; 2003 May; 14(5):499-507. PubMed ID: 12776867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eplerenone-mediated regression of electrical activation delays and myocardial fibrosis in heart failure.
    J Cardiovasc Electrophysiol; 2014 May; 25(5):556-577. PubMed ID: 24612029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure.
    Suzuki G; Morita H; Mishima T; Sharov VG; Todor A; Tanhehco EJ; Rudolph AE; McMahon EG; Goldstein S; Sabbah HN
    Circulation; 2002 Dec; 106(23):2967-72. PubMed ID: 12460880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction.
    Udelson JE; Feldman AM; Greenberg B; Pitt B; Mukherjee R; Solomon HA; Konstam MA
    Circ Heart Fail; 2010 May; 3(3):347-53. PubMed ID: 20299607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans.
    Sanders P; Morton JB; Davidson NC; Spence SJ; Vohra JK; Sparks PB; Kalman JM
    Circulation; 2003 Sep; 108(12):1461-8. PubMed ID: 12952837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldosterone synthase inhibition improves cardiovascular function and structure in rats with heart failure: a comparison with spironolactone.
    Mulder P; Mellin V; Favre J; Vercauteren M; Remy-Jouet I; Monteil C; Richard V; Renet S; Henry JP; Jeng AY; Webb RL; Thuillez C
    Eur Heart J; 2008 Sep; 29(17):2171-9. PubMed ID: 18586661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction.
    Fraccarollo D; Galuppo P; Schmidt I; Ertl G; Bauersachs J
    Cardiovasc Res; 2005 Jul; 67(1):97-105. PubMed ID: 15949473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of eplerenone on transcriptional factors and mRNA expression related to cardiac remodelling after myocardial infarction.
    Enomoto S; Yoshiyama M; Omura T; Matsumoto R; Kusuyama T; Kim S; Izumi Y; Akioka K; Iwao H; Takeuchi K; Yoshikawa J
    Heart; 2005 Dec; 91(12):1595-600. PubMed ID: 15797934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of pacing site on myocardial transmural dispersion of repolarization in intact normal and dilated cardiomyopathy dogs].
    Bai R; Pu J; Liu N; Lu JG; Zhou Q; Ruan YF; Niu HY; Wang L
    Sheng Li Xue Bao; 2003 Dec; 55(6):722-30. PubMed ID: 14695492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xanthine oxidase inhibition prevents atrial fibrillation in a canine model of atrial pacing-induced left ventricular dysfunction.
    Sakabe M; Fujiki A; Sakamoto T; Nakatani Y; Mizumaki K; Inoue H
    J Cardiovasc Electrophysiol; 2012 Oct; 23(10):1130-5. PubMed ID: 22587612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Additive improvement of left ventricular remodeling by aldosterone receptor blockade with eplerenone and angiotensin II type 1 receptor antagonist in rats with myocardial infarction].
    Yoshiyama M; Omura T; Yoshikawa J
    Nihon Yakurigaku Zasshi; 2004 Aug; 124(2):83-9. PubMed ID: 15277726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: eplerenone: an underused medication?
    Abuannadi M; O'Keefe JH
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):318-25. PubMed ID: 20876342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spironolactone improves the arrhythmogenic substrate in heart failure by preventing ventricular electrical activation delays associated with myocardial interstitial fibrosis and inflammation.
    Esposito CT; Varahan S; Jeyaraj D; Lu Y; Stambler BS
    J Cardiovasc Electrophysiol; 2013 Jul; 24(7):806-12. PubMed ID: 23489714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of omapatrilat on cardiac nerve sprouting and structural remodeling in experimental congestive heart failure.
    Cha YM; Redfield MM; Shah S; Shen WK; Fishbein MC; Chen PS
    Heart Rhythm; 2005 Sep; 2(9):984-90. PubMed ID: 16171755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential morphometric and ultrastructural remodelling in the left atrium and left ventricle in rapid ventricular pacing-induced heart failure.
    O'Brien DW; Fu Y; Parker HR; Chan SY; Idikio H; Scott PG; Jugdutt BI
    Can J Cardiol; 2000 Nov; 16(11):1411-9. PubMed ID: 11109038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eplerenone improves prognosis in postmyocardial infarction diabetic patients with heart failure: results from EPHESUS.
    O'Keefe JH; Abuissa H; Pitt B
    Diabetes Obes Metab; 2008 Jun; 10(6):492-7. PubMed ID: 17490427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.